---
figid: PMC11011055__cancers-16-01334-g007
figtitle: Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11011055
filename: cancers-16-01334-g007.jpg
figlink: /pmc/articles/PMC11011055/figure/cancers-16-01334-f007/
number: F7
caption: The use of small-molecule metabolic inhibitors, such as the fluorinated sialic
  acid analogue 3Fax-Neu5Ac, to obstruct the synthesis of sialylation pathway. As
  a result, the cell surface-expressed glycans are not capped with sialic acid, and
  their interaction with Siglecs is blocked.
papertitle: Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer.
reftext: Ramya Ayyalasomayajula, et al. Cancers (Basel). 2024 Apr;16(7):1334.
year: '2024'
doi: 10.3390/cancers16071334
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: MUC1 | Siglecs | sialoglycans | glycocode | immune evasion
automl_pathway: 0.9335601
figid_alias: PMC11011055__F7
figtype: Figure
redirect_from: /figures/PMC11011055__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11011055__cancers-16-01334-g007.html
  '@type': Dataset
  description: The use of small-molecule metabolic inhibitors, such as the fluorinated
    sialic acid analogue 3Fax-Neu5Ac, to obstruct the synthesis of sialylation pathway.
    As a result, the cell surface-expressed glycans are not capped with sialic acid,
    and their interaction with Siglecs is blocked.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GNE
  - ATP7A
  - NANS
  - MATN1
  - GAL
  - GALP
  - UDP-GlcNAc
  - CMP
  - Nucleus
  - CMP-Sialic acid
  - Inhibitors
  - GalNAc
  - Gal
  - Neu5Ac
---
